Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

Gene R. Quinn, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Christopher C. Nessel, Manesh R. Patel, Jonathan P. Piccini, Daniel E. Singer

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages3
JournalCirculation
Volume134
Publication statusPublished - 11 Nov 2016
EventScientific Sessions of the American-Heart-Association / Resuscitation Science Symposium - New Orleans, Lao People's Democratic Republic
Duration: 12 Nov 201616 Nov 2016

Cite this

Quinn, G. R., Hellkamp, A. S., Becker, R. C., Berkowitz, S. D., Breithardt, G., Fox, K. A., ... Singer, D. E. (2016). Selective Serotonin Reuptake Inhibitors Increase Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. Circulation, 134.